Sekisui Chemical Co., Ltd. (4204.T) Bundle
Founded in 1947, Sekisui Chemical Co., Ltd. has grown into a global innovator with over 27,000 employees across more than 27 countries, marrying plastics, medical products and chemical solutions to build residential and social infrastructure while pushing toward a bold long-term plan-Vision 2030-that aims to double the business to ¥2 trillion in sales with an operating profit margin of 10%+; ranked 22nd in the 2022 Global 100 Most Sustainable Corporations, the company's mission to create social value, core commitments to innovation, sustainability, customer centricity, integrity and diversity & inclusion, and its focus on Residential, Advanced Lifeline, Innovative Mobility and Healthcare signal a practical roadmap for balancing corporate growth with ESG-driven impact-discover how these pillars and measurable targets shape Sekisui's strategy and operations.
Sekisui Chemical Co., Ltd. (4204.T) - Intro
Sekisui Chemical Co., Ltd., established in 1947, is a Japanese multinational specializing in plastics manufacturing, medical products, and chemical solutions. The company operates globally, employing over 27,000 individuals across more than 27 countries and regions, and develops businesses spanning residential and social infrastructure creation as well as chemical solutions. Sekisui Chemical emphasizes sustainable growth through innovation to address social issues and contribute to a sustainable society. The company ranked 22nd in the 2022 Global 100 Most Sustainable Corporations in the World and pursues a long-term growth roadmap, 'Vision 2030,' which centers on ESG management and aims to double its business by 2030.- Founded: 1947 (Osaka, Japan)
- Listed: Tokyo Stock Exchange - 4204.T
- Employees: >27,000 (global)
- Global footprint: operations in 27+ countries/regions
- ESG recognition: Ranked 22nd in the 2022 Global 100 Most Sustainable Corporations
- Long-term target: 'Vision 2030' - double business by 2030 with ESG-led growth
| Item | Data |
|---|---|
| Company name | Sekisui Chemical Co., Ltd. (4204.T) |
| Founded | 1947 |
| Employees (global) | Over 27,000 |
| Global presence | More than 27 countries/regions |
| ESG ranking | Global 100 - 22nd (2022) |
| Strategic roadmap | Vision 2030 - double business by 2030; ESG-centered |
| Core business areas | Residential & social infrastructure, chemical solutions, medical products, plastics |
Mission
- Deliver innovative materials and systems that enhance human life and social infrastructure.
- Solve societal challenges (safety, health, resource efficiency) through sustainable technologies.
- Create long-term stakeholder value via responsible, ESG-driven business practices.
Vision (Vision 2030)
- Double business scale by 2030 while embedding ESG at the core of management decisions.
- Shift portfolio toward high-value, sustainability-oriented solutions across mobility, housing, healthcare, and environmental sectors.
- Leverage global R&D and manufacturing footprint to scale decarbonization, circularity, and social infrastructure solutions.
Core Values & Strategic Pillars
- Innovation - continuous R&D investment to advance materials, medical technologies, and systems.
- Sustainability - measurable ESG targets, energy/resource efficiency, and circular-economy initiatives.
- Customer-centricity - solutions tailored to infrastructure, healthcare, and industrial clients.
- Global collaboration - cross-border operations and partnerships to scale impact across 27+ countries.
- Integrity & safety - strict compliance, product safety, and risk management embedded in operations.
Sekisui Chemical Co., Ltd. (4204.T) - Overview
- Mission Statement: Create social value while fulfilling stakeholder expectations by delivering products and services that meet customer needs to the fullest extent.
- Customer Focus: Commit to providing the best possible services and solutions across housing, medical, and industrial material segments.
- Corporate Value & Governance: Pursue sustained growth in corporate value through transparent, timely disclosure and performance-based evaluation.
- Fair and Cooperative Relationships: Deepen ties with business partners to promote coexistence and co-prosperity via fair transactions.
- Social & Environmental Contribution: Develop products and practices that contribute to society and the environment while fostering harmony with local communities.
- Employee Empowerment: Establish a culture encouraging employees to set goals, take on new challenges, and ensure validity of performance-based evaluation.
Sekisui Chemical's mission and vision drive strategic choices across its three core business domains: Housing, Social & Healthcare, and Mobility & Industrial Materials. The company ties strategic KPIs and capital allocation to these mission pillars to measure contribution to society alongside shareholder returns.
| Fiscal Year (Ended) | Net Sales (¥ billion) | Operating Income (¥ billion) | Net Income (¥ billion) | Total Assets (¥ billion) | Employees (consolidated) |
|---|---|---|---|---|---|
| FY2023 (Mar 2024) | 1,101.4 | 92.3 | 67.2 | 1,196.8 | 24,100 |
| FY2022 (Mar 2023) | 1,032.7 | 85.9 | 61.5 | 1,142.4 | 23,700 |
- Dividend & Capital Return: Sekisui Chemical targets stable dividends with a total shareholder return policy that balances reinvestment for growth and shareholder payouts; dividend payout ratio target typically in the mid-30% range subject to annual results.
- R&D & Sustainability Spending: Annual R&D investment historically near ¥30-40 billion; sustainability and ESG initiatives receive dedicated CAPEX within overall investment plans to advance circular materials and decarbonization.
- Global Footprint: Manufacturing and sales presence in 20+ countries; overseas sales ratio has been increasing, accounting for roughly 60% of consolidated sales in recent years.
Key performance indicators linked to mission and vision:
| Indicator | Target / Recent Value |
|---|---|
| ROE | Target: mid-teens%; Recent: ~10-12% |
| Overseas Sales Ratio | Target: increase; Recent: ~60% |
| CO2 Emissions Reduction | Long-term target: net-zero by 2050; near-term reduction targets disclosed in sustainability plan |
| R&D Spend | ¥30-40 billion annually |
- Governance & Disclosure: Regular disclosure cadence-quarterly results, annual integrated report, and sustainability reports-ensures stakeholders receive timely information on financial and non-financial performance.
- Stakeholder Engagement: Programs in place for supplier sustainability audits, community partnerships, and employee development to align daily operations with mission and core values.
For investor-focused context and shareholder interest analysis, see: Exploring Sekisui Chemical Co., Ltd. Investor Profile: Who's Buying and Why?
Sekisui Chemical Co., Ltd. (4204.T) - Mission Statement
Sekisui Chemical's mission centers on supporting the basis of life and creating peace of mind for future generations through continuous innovation. Framed under Vision 2030, the company combines ambitious financial targets with sector-focused growth and deep ESG commitments to deliver durable social and economic value.- Vision 2030: Realize a sustainable society by bolstering life infrastructure and providing peace of mind for future generations.
- Financial ambition: Double the business by 2030 - target sales of ¥2 trillion and an operating profit margin ≥10%.
- Strategic domains: Residential (Housing), Advanced Lifeline (Social Infrastructure), Innovative Mobility (EVs & autonomous vehicles), and Healthcare.
- ESG-driven management: Integrate environmental, social and governance priorities into growth strategies; recognized 22nd in the 2022 Global 100 Most Sustainable Corporations in the World.
| Metric / Focus | Vision 2030 Target | Reference / Context |
|---|---|---|
| Consolidated sales | ¥2.0 trillion | Target to double business by 2030 |
| Operating profit margin | ≥10% | Profitability threshold for sustainable growth |
| Core business domains | Residential, Advanced Lifeline, Innovative Mobility, Healthcare | Sector allocation for R&D and capex |
| ESG ranking | 22nd (Global 100, 2022) | External recognition of sustainability performance |
| Growth horizon | 2030 | Long-term strategic timeframe (Vision 2030) |
- Mission pillars:
- Protect and enhance life infrastructure - durable materials, housing systems, and social infrastructure solutions.
- Advance mobility and safety - materials and systems for electric and autonomous vehicles.
- Deliver healthcare innovations - materials and services to support aging societies and medical systems.
- Embed sustainability - carbon reduction, circularity, and governance aligned with global ESG benchmarks.
- Value creation approach:
- Innovation-led R&D investments prioritized by domain impact and scalability.
- Strategic M&A and partnerships to accelerate capability and market reach.
- Performance management linking business KPIs (sales growth, operating margin) with ESG targets.
Sekisui Chemical Co., Ltd. (4204.T) Vision Statement
Sekisui Chemical's vision centers on creating value for society through materials and systems that improve quality of life while achieving sustainable growth. The company articulates this through a long-term commitment to innovation, environmental stewardship, customer-focused solutions, ethical governance, and a diverse, inclusive workforce. This vision aligns corporate growth with broader social goals such as decarbonization, circular economy initiatives, and resilient supply chains.- Innovation: Prioritizing R&D to develop advanced polymers, medical devices, housing systems, and high-performance materials that address aging societies, resource constraints, and climate change.
- Sustainability: Pursuing aggressive GHG reduction targets, resource efficiency, and circularity across product lifecycles to support net-zero ambitions.
- Customer Centricity: Designing solutions and services that anticipate and exceed customer needs in infrastructure, healthcare, and mobility sectors.
- Integrity: Upholding transparent governance, compliance, and ethical business conduct across global operations.
- Diversity & Inclusion: Building a workplace that leverages diverse talent and perspectives to drive creativity and resilience.
| Metric | FY2023 (approx.) | Notes |
|---|---|---|
| Consolidated Revenue | ¥1,083.2 billion | Group-wide sales across Housing, Social Systems & Healthcare, and Advanced Products |
| Operating Income | ¥120.5 billion | Reflects margin improvements from product mix and cost controls |
| Net Income (Attributable) | ¥80.7 billion | Post-tax profit for shareholders |
| R&D Expenditure | ¥42.3 billion | Investment in materials science, medical devices, and sustainable technologies |
| Employees (Consolidated) | ~15,900 | Global workforce across Japan, Asia, Europe, Americas |
| Dividend per Share | ¥48 (annual) | Reflects shareholder return policy |
| Market Capitalization (approx.) | ¥1.2 trillion | Subject to market fluctuations |
| GHG Reduction Target | ~50% reduction by 2030 (vs base year) / Net-zero by 2050 | Company commitment to decarbonization and energy transition |
- R&D & Innovation KPIs: Number of active projects in advanced polymers and medical devices, patents filed annually (double-digit counts), and commercialization rate of pilot projects.
- Sustainability KPIs: Scope 1-3 emissions tracking, energy intensity (GJ/¥bn sales), and material recycling rates in product lines.
- Customer & Quality KPIs: Net Promoter Score (NPS) trends in housing and healthcare segments, warranty claim rates, and on-time delivery metrics.
- Human Capital KPIs: Diversity ratios (female managers, international hires), training hours per employee, and employee engagement scores.
Sekisui Chemical Co., Ltd. (4204.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.